PressOctober 18, 2023 Mushrooms Inc (OTC:MSRM) Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery
PressOctober 18, 2023 Lucy Scientific Discovery’s Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health
PressOctober 18, 2023 Mydecine Innovations Group gearing up for human trials after completing Aquis listing
PressOctober 17, 2023 Diamond Therapeutics Announces First Patient Enrolled in FDA-authorized Study Evaluating Low-Dose Psilocybin in Human Subjects with Demoralization
PressOctober 17, 2023 Revive Therapeutics Enters into Agreement with Defence Research and Development Canada for Evaluating Bucillamine for Nerve Agent Exposure
PressOctober 16, 2023 Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
PressOctober 13, 2023 Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders
PressOctober 13, 2023 Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
PressOctober 12, 2023 Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
PressOctober 10, 2023 Red Light Holland Fires Mia Khalifa for Her Appalling Tweets and Comments Condoning Hamas Terrorist Attacks in Israel
PressOctober 10, 2023 Lophos Secures Game-Changing Controlled Substance Dealer’s License with the Expertise of Canalytica Corp.
PressOctober 10, 2023 Filament Health Announces Health Canada Authorization for Phase 2 Clinical Trial Studying Botanical Psilocybin for Opioid Use Disorder
PressOctober 10, 2023 MindBio Therapeutics Corp. Begins Selection of Participants for its Phase 2 Randomized Double-Blind and Placebo Controlled Clinical Trial in Advanced Stage Cancer Patients Using Microdoses of Lylergic Acid Diethylamide and Meaning Centred Psychotherapy
PressOctober 10, 2023 Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
PressOctober 10, 2023 Origin Therapeutics Announces Results of Annual General and Special Meeting of Shareholders
PressOctober 10, 2023 Safe Supply and Origin Therapeutics Receive Conditional Approval for Listing On the CSE
PressOctober 9, 2023 Medicinal Mushroom Market Anticipated to Reach USD 62.0 Bn by 2032 with 8.7% CAGR | Analysis by Marketresearch.biz
PressOctober 9, 2023 Atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
PressOctober 9, 2023 Cybin to Present an Abstract and Moderate a Psychedelic Workshop at the 6th Annual Neuropsychiatric Drug Development Summit
PressOctober 5, 2023 Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
